A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

This study has been completed.
Sponsor:
Information provided by:
Ascenta Therapeutics
ClinicalTrials.gov Identifier:
NCT00286806
First received: February 3, 2006
Last updated: August 20, 2010
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 12, 2010